Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 112

    Delhi High Court: E-pharmacies claim they are like Swiggy, only deliver drugs

    Delhi High Court: E-pharmacies claim they are like Swiggy, only deliver drugs

    Farhat Nasim4 July 2019 5:04 PM IST
    The e-pharmacies told a bench of Chief Justice D N Patel and Justice C Hari Shankar that just like Swiggy does not require a restaurant license to...
    CDSCO Warning: Beware of hacking risk in Medtronic insulin pumps

    CDSCO Warning: Beware of hacking risk in Medtronic insulin pumps

    Farhat Nasim4 July 2019 11:40 AM IST
    New Delhi: Months after issuing an advisory against three models of pacemakers sold by the world’s largest medical device manufacturer, Medtronic,...
    Aurobindo Pharma pulled up by USFDA for repeated CGMP failures

    Aurobindo Pharma pulled up by USFDA for repeated CGMP failures

    Medical Dialogues Bureau4 July 2019 10:00 AM IST
    The repeated failures at multiple sites of Aurobindo Pharma demonstrate that management oversight and control over the manufacture of drugs are...
    Lupin gets USFDA nod for generic versions of Sensipar tablets, Omidria intraocular solution

    Lupin gets USFDA nod for generic versions of Sensipar tablets, Omidria intraocular solution

    Medical Dialogues Bureau4 July 2019 9:45 AM IST
    Cinacalcet tablets are a generic version of Amgen Inc's Sensipar tablets in the same strengths, said Lupin.New Delhi: Drug firm Lupin on Wednesday...
    Biovac finalizes deal to manufacture Pfizer, Sanofi vaccines

    Biovac finalizes deal to manufacture Pfizer, Sanofi vaccines

    Medical Dialogues Bureau4 July 2019 9:00 AM IST
    The new production lines follow years of technology transfers and skills upgrades with partners Sanofi and Pfizer in Africa’s largest pharmaceutical...
    FIRST: Dr Reddys unveils generic version of Hemabate injection indicated for abortion

    FIRST: Dr Reddys unveils generic version of Hemabate injection indicated for abortion

    Farhat Nasim3 July 2019 3:30 PM IST
    The product is a generic version of Pfizer's Hemabate injection in the strength of 250 mcg/mL, it added.NEW DELHI: Dr Reddy's Laboratories Wednesday...
    Patients save Rs 12447 crore due to price fixation of essential medicines by NPPA

    Patients save Rs 12447 crore due to price fixation of essential medicines by NPPA

    Medical Dialogues Bureau3 July 2019 2:23 PM IST
    Highlighting the role of the National Pharmaceutical Pricing Authority (NPPA), Gowda said the Authority has taken important measures to check prices...
    Strides Pharma gets USFDA warning letter for Puducherry facility

    Strides Pharma gets USFDA warning letter for Puducherry facility

    Farhat Nasim3 July 2019 11:38 AM IST
    The 10 abbreviated new drug applications (ANDAs) pending approval from the Puducherry facility will get deferred till the site is reclassified,...
    Sanofi gets European nod for Libtayo to treat cutaneous squamous cell carcinoma

    Sanofi gets European nod for Libtayo to treat cutaneous squamous cell carcinoma

    Medical Dialogues Bureau3 July 2019 9:30 AM IST
    Libtayo is being jointly developed by Sanofi and Regeneron under a global collaboration agreement.PARIS: The European Commission (EC) has granted...
    Merck Foundation, First Lady of Guinea collaborate to launch first Merck Health Media Training

    Merck Foundation, First Lady of Guinea collaborate to launch first Merck Health Media Training

    Medical Dialogues Bureau3 July 2019 9:00 AM IST
    "The training program is a part of 'Merck More than a Mother' community awareness Program and was organized for the first time in Guinea for local...
    Pfizer receives USFDA approval for biosimilar to Avastin

    Pfizer receives USFDA approval for biosimilar to Avastin

    Farhat Nasim2 July 2019 2:24 PM IST
    ZIRABEV is a mAb biosimilar of the reference product, Avastin, which works by inhibiting the formation of new blood cells (angiogenesis) by...
    Novartis introduces 26 week gender-neutral parental leave for birth, adoption, surrogacy

    Novartis introduces 26 week gender-neutral parental leave for birth, adoption, surrogacy

    Farhat Nasim2 July 2019 12:55 PM IST
    The new parental leave policy is effective July 1, 2019 and applies to birthing and non-birthing parents in the case of birth, adoption and surrogacy,...
    PrevNext

    Popular Stories

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day

    Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok